VTE Prophylaxis
Venous thromboembolism (VTE) may contribute to up to 12% of deaths in ICU and is the No.1 preventable cause of hospital death; asymptomatic events range from 10-80% in various medical and surgical groups
Peripheral Intravenous Cannula
Peripheral Intravenous Cannula (PIVC) aka venflon: Uses; IV fluid administration; blood sampling; drug administration; needle thoracostomy for tension pneumothorax; needle cricothyroidotomy
Oropharyngeal Airway
Oropharyngeal Airway (OPA): Lifts the tongue off the posterior pharyngeal wall to prevent airway obstruction; bite block; assist oropharyngeal suctioning; promotes moulding of the face of a mask for manual ventilation
Non-rebreathing Oxygen Mask
Non-rebreathing (NRB) Oxygen Mask; delivery of high FiO2 in the spontaneously breathing patient
Non-invasive Blood Pressure
non-invasive blood pressure measurement involves the application of a pressure cuff and can be performed manually (listening for Korotkoff sounds as the pressure is released
Mechanical Circulatory Support – A Practical Approach
Mechanical Circulatory Support
Magill forceps
Magill forceps: aid passage of an endotracheal tube into the larynx (e.g. nasal intubation); aid gastric tube passage into the oesophagus; remove foreign bodies from the airway/ pharynx; place pharyngeal packs (e.g. bleeding)
Laryngoscope and blades
Laryngoscope - device used to visualise the vocal cords to facilitate intubation
Jugular Bulb Oxygen Saturation
Jugular Bulb Oxygen Saturation = measure of oxygen delivery and extraction to the brain; assess information about cerebral metabolism and blood flow
IVC Filter
IVC Filter filter placed in the inferior vena cava (IVC) to prevent clot passage; first introduced in the 1960s
Intraosseous access
Intraosseous (IO) access can be obtained using manual or drill-inserted devices for insertion of specialised needles; IO access uses the medullary space as a non collapsible entry point into the systemic venous system
CICM SAQ 2015.2 Q19
Question a) Interpret the three pharmacodynamic (PD) profiles, labelled Scenario 1, Scenario 2 and Scenario 3, shown below. b) For each PD profile, describe how you would optimise the dose and/or frequency of antibiotic if prescribing: i) a beta lactam…